CN Patent
CN117466913A — 一种5,6-二氢苯并[f]咪唑并[1,2-d][1,4]噁吖庚英化合物的晶型及其制备方法
Assigned to Guangzhou Jiayue Pharmaceutical Technology Co ltd · Expires 2024-01-30 · 2y expired
What this patent protects
一种5,6‑二氢苯并[f]咪唑并[1,2‑d][1,4]噁吖庚英化合物的晶型及其制备方法,还包括所述晶型在制备治疗相关疾病的药物中的应用。具体公开了式(I)化合物的晶型及其制备方法。
USPTO Abstract
一种5,6‑二氢苯并[f]咪唑并[1,2‑d][1,4]噁吖庚英化合物的晶型及其制备方法,还包括所述晶型在制备治疗相关疾病的药物中的应用。具体公开了式(I)化合物的晶型及其制备方法。
Drugs covered by this patent
- Itovebi (INAVOLISIB) · Genentech Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.